Literature DB >> 30957240

Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.

Ainhoa Oñatibia-Astibia1, Amaia Malet-Larrea1, Belen Larrañaga1, Miguel Ángel Gastelurrutia2, Begoña Calvo3, Dulce Ramírez4, Ignacio Cantero4, Ángel Garay1, Estibaliz Goyenechea1.   

Abstract

OBJECTIVE: To evaluate the impact of health professionals' intervention on adherence to statins, the influence on total cholesterol levels, and lifestyle patterns in patients with hypercholesterolemia and analyze the differences according to the center of recruitment. STUDY
SETTING: Forty-six community pharmacies and 50 primary care centers of Spain. STUDY
DESIGN: Randomized controlled trial design (n = 746). Patients were assigned into adherent (ADH) or nonadherent group depending on their initial adherence to statins. Nonadherent patients were randomly assigned to intervention (INT) or nonintervention (NOINT) group. Patients enrolled in the INT group received an intervention depending on the cause of nonadherence. Patients in the ADH and NOINT groups received usual care. Intention-to-treat (ITT) analysis was performed with multiple imputation to replace the missing data. DATA COLLECTION: Adherence, total cholesterol levels, and lifestyle behaviors.
FINDINGS: The odds of becoming adherent during the 6 months was higher in the INT group compared to the NOINT group (OR = 1,49; 95% CI: 1.30-1.76; P < 0.001), especially in the community pharmacy group (OR = 2.34; 95% CI: 1.81-3.03; P < 0.001). Adherent patients showed lower values of total cholesterol compared with nonadherent patients at baseline (ADH: 200.3 mg/dL vs NOADH: 216.7 mg/dL; P < 0.001) and at the endpoint (ADH: 197.3 mg/dL vs NOADH: 212.2 mg/dL; P < 0.001). More patients enrolled in the INT group practices exercise at the end of the study (INT: +26.6 percent; P = 0.002), and a greater number of patients followed a diet to treat hypercholesterolemia (+30.2 percent; P < 0.001).
CONCLUSIONS: The intervention performed by health professionals, especially by community pharmacists, improved adherence to statins by hypercholesterolemic patients, and this improvement in adherence was accompanied by a reduction in total cholesterol levels and a healthier lifestyle. © Health Research and Educational Trust.

Entities:  

Keywords:  clinical outcomes; community pharmacy; compliance; hypercholesterolemia; lipid-lowering drugs

Mesh:

Substances:

Year:  2019        PMID: 30957240      PMCID: PMC6505412          DOI: 10.1111/1475-6773.13152

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  45 in total

Review 1.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  Cardiovascular risk factor assessments and health behaviours in patients using statins compared to a non-treated population.

Authors:  Per Lytsy; Gunilla Burell; Ragnar Westerling
Journal:  Int J Behav Med       Date:  2012-06

3.  Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.

Authors:  Robert S Rosenson; Shia T Kent; Todd M Brown; Michael E Farkouh; Emily B Levitan; Huifeng Yun; Pradeep Sharma; Monika M Safford; Meredith Kilgore; Paul Muntner; Vera Bittner
Journal:  J Am Coll Cardiol       Date:  2015-01-27       Impact factor: 24.094

4.  Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.

Authors:  M A Faulkner; E C Wadibia; B D Lucas; D E Hilleman
Journal:  Pharmacotherapy       Date:  2000-04       Impact factor: 4.705

Review 5.  Statins and Nonadherence: Should We RELATE Better?

Authors:  Alexander Turin; Jay Pandit; Neil J Stone
Journal:  J Cardiovasc Pharmacol Ther       Date:  2015-03-31       Impact factor: 2.457

6.  Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Authors:  Vanessa Selak; C Raina Elley; Chris Bullen; Sue Crengle; Angela Wadham; Natasha Rafter; Varsha Parag; Matire Harwood; Robert N Doughty; Bruce Arroll; Richard J Milne; Dale Bramley; Linda Bryant; Rod Jackson; Anthony Rodgers
Journal:  BMJ       Date:  2014-05-27

Review 7.  The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review.

Authors:  Ross J Simpson; Philip Mendys
Journal:  J Clin Lipidol       Date:  2010-09-08       Impact factor: 4.766

8.  Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial.

Authors:  Carol L Armour; Helen K Reddel; Kate S LeMay; Bandana Saini; Lorraine D Smith; Sinthia Z Bosnic-Anticevich; Yun Ju Christine Song; M Chehani Alles; Deborah L Burton; Lynne Emmerton; Kay Stewart; Ines Krass
Journal:  J Asthma       Date:  2012-12-28       Impact factor: 2.515

9.  Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.

Authors:  Ainhoa Oñatibia-Astibia; Amaia Malet-Larrea; Belen Larrañaga; Miguel Ángel Gastelurrutia; Begoña Calvo; Dulce Ramírez; Ignacio Cantero; Ángel Garay; Estibaliz Goyenechea
Journal:  Health Serv Res       Date:  2019-04-07       Impact factor: 3.402

Review 10.  Evidence of lifestyle modification in the management of hypercholesterolemia.

Authors:  G S Mannu; M J S Zaman; A Gupta; H U Rehman; P K Myint
Journal:  Curr Cardiol Rev       Date:  2013-02-01
View more
  3 in total

1.  Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.

Authors:  Ainhoa Oñatibia-Astibia; Amaia Malet-Larrea; Belen Larrañaga; Miguel Ángel Gastelurrutia; Begoña Calvo; Dulce Ramírez; Ignacio Cantero; Ángel Garay; Estibaliz Goyenechea
Journal:  Health Serv Res       Date:  2019-04-07       Impact factor: 3.402

2.  Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.

Authors:  Renata Cristina Rezende Macedo do Nascimento; Tanja Mueller; Brian Godman; Sean MacBride Stewart; Simon Hurding; Francisco de Assis Acurcio; Augusto Afonso Guerra Junior; Juliana Alvares Teodoro; Alec Morton; Marion Bennie; Amanj Kurdi
Journal:  Br J Clin Pharmacol       Date:  2020-05-30       Impact factor: 4.335

Review 3.  Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.

Authors:  Vicente F Gil-Guillen; Alejandro Balsa; Beatriz Bernárdez; Carmen Valdés Y Llorca; Emilio Márquez-Contreras; Juan de la Haba-Rodríguez; Jose M Castellano; Jesús Gómez-Martínez
Journal:  Int J Environ Res Public Health       Date:  2022-09-23       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.